Roghani-Dehkordi Farshad, Hashemifard Omid, Sadeghi Masoumeh, Mansouri Rohollah, Akbarzadeh Mehdi, Dehghani Asieh, Akbari Mojtaba
Associate Professor, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Cardiologist, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
ARYA Atheroscler. 2018 Mar;14(2):95-100. doi: 10.22122/arya.v14i2.1743.
Trans-radial and trans-ulnar accesses have been practiced and recommended as default and alternative techniques for coronary angiography and angioplasty in recent years. In this study, we present new innovative approaches using more distal access points, i.e. trans-snuff box and trans-palmar approaches.
We conducted dorsal hand access (trans-snuff box) for angiography and/or angioplasty on 235 patients, and trans-palmar access (superficial palmar branch of ulnar artery) on 175 patients in 3 hospitals in Isfahan City, Iran.
In 221 patients out of 235 ones (94.1%) [men: 76.5%, age: 57.4 ± 10.4 (years); women: 23.5%, age: 62.4 ± 9.5 (years)], our procedure through snuff box (dorsal hand) was successfully performed. In 159 patients out of 175 ones (90.8%) [men: 76.0%, age: 58.1 ± 10.5 (years); women: 24.0%, age: 61.2 ± 9.6 (years)], our procedure through palmar artery was successfully performed. In total, the evaluated patients had mild pain (3.4% for snuff box, and 4.5% for palmar), ecchymosis in distal forearm (5.1% for snuff box, and 2.8% for palmar), with no major complications even one (amputation, infection, thrombosis, need for surgery, hand dysfunction, nerve palsy, and so forth). In addition, percutaneous coronary intervention (PCI) was done in 28.9% and 18.2% of cases via snuff box and palmar approaches, respectively. Meanwhile, hemostasis was very fast and easy with discharge time equivalent to other upper limb accesses.
Although our procedures are at their early stages with about a follow-up period of 3-15 months, more researches are recommended to be conducted in forthcoming months and years, and this new innovative approaches could be suggested safe, feasible, and reliable with low complications.
近年来,经桡动脉和经尺动脉途径已被应用并推荐为冠状动脉造影和血管成形术的常规及替代技术。在本研究中,我们展示了使用更远端穿刺点的创新方法,即经鼻烟窝和经掌部途径。
我们在伊朗伊斯法罕市的3家医院,对235例患者进行了用于血管造影和/或血管成形术的手背穿刺(经鼻烟窝),以及对175例患者进行了经掌部穿刺(尺动脉掌浅支)。
在235例患者中的221例(94.1%)[男性:76.5%,年龄:57.4±10.4(岁);女性:23.5%,年龄:62.4±9.5(岁)]中,我们经鼻烟窝(手背)的操作成功完成。在175例患者中的159例(90.8%)[男性:76.0%,年龄:58.1±10.5(岁);女性:24.0%,年龄:61.2±9.6(岁)]中,我们经掌动脉的操作成功完成。总体而言,评估的患者有轻微疼痛(经鼻烟窝为3.4%,经掌部为4.5%),前臂远端有瘀斑(经鼻烟窝为5.1%,经掌部为2.8%),甚至没有发生一例严重并发症(截肢、感染、血栓形成、手术需求、手部功能障碍、神经麻痹等)。此外,分别有28.9%和18.2%的病例通过经鼻烟窝和经掌部途径进行了经皮冠状动脉介入治疗(PCI)。同时,止血非常迅速且容易,出院时间与其他上肢穿刺途径相当。
尽管我们的操作尚处于早期阶段,随访期约为3至15个月,但建议在未来数月和数年进行更多研究,并且这种新的创新方法可能是安全、可行且可靠的,并发症较少。